Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR6 | P51684 | 1/20 | 0.46 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.46 |
| ▸ | CCR5 | P51681 | 6/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7813133 | 0.94 | ENPP2 (0.51) | CCR6PAX8CCR5ENPP2SIGMAR1 | |
| SCHEMBL10325504 | 0.93 | SIGMAR1 (0.46) | CCR6PAX8CCR5ENPP2SIGMAR1 | |
| SCHEMBL13641301 | 0.93 | SIGMAR1 (0.46) | CCR6PAX8CCR5ENPP2SIGMAR1 | |
| SCHEMBL30802298 | 0.91 | SLC6A2 (0.45) | CCR6PAX8CCR5CHRM3SLC6A2 | |
| SCHEMBL30802466 | 0.90 | SMN1; SMN2 (0.49) | CCR5SIGMAR1CHRM2CHRM5CHRM1 | |
| SCHEMBL4964527 | 0.88 | CCR5 (0.47) | CCR5ENPP2SIGMAR1CHRM2CHRM5 | |
| Hydrochloric Acid SCHEMBL27382588 | 0.86 | CCR5 (0.43) | CCR6PAX8CCR5ENPP2SIGMAR1 | |
| SCHEMBL2713759 | 0.85 | CHRM2 (0.44) | CCR6PAX8CCR5ENPP2SIGMAR1 | |
| SCHEMBL14975918 | 0.84 | CCR5 (0.46) | CCR5ENPP2SIGMAR1CHRM2CHRM5 | |
| SCHEMBL13434086 | 0.84 | CCR5 (0.59) | CCR5SIGMAR1ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083708-A1 | IL-17 MODULATORS AND USES THEREOF | NNOCARE PHARMA INC (US) | 2026-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083708-A1 | IL-17 MODULATORS AND USES THEREOF | IL17A, IL2, IL23R | CCR6 18/4885PAX8 2568/4885CCR5 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.